Aesthetics & botox stocks
미용·보톡스
What are Aesthetics & botox stocks in Korea?
The Aesthetics & botox theme on jonbur groups 25 Korean stocks listed on KOSPI and KOSDAQ, worth ₩23T in total. On Oct 29, 2026 the group moved down 1.46% (weighted by market value); the largest members are APR, PharmaResearch, Hugel.
Key facts
- Stocks
- 25
- Total market value
- ₩23T
- Day's move
- −1.46%
- As of
- Oct 29, 2026
- Largest members
- APR, PharmaResearch, Hugel
Earnings tracker · 3Q 2026
Reporting season · reports due by Nov 14
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| APR | Oct 30Preliminary | ₩773B | +100.3% | ₩161B | +67.1% | +319.6% | 20.8%24.9% |
| Metacare | Oct 26Preliminary | ₩567M | −94.7% | −₩229M | Turned to loss | Turned to loss | −40.4%1.1% |
| Shaperon | Oct 1Preliminary | ₩4.7B | +2,683.4% | — | — | — | — |
| Dong-A Pharmaceutical | Expected around Oct 29 | ||||||
| Hyundai Bioland | Expected around Nov 3 | ||||||
| Hugel | Expected around Nov 4 | ||||||
| Daewoong Pharma | Expected around Nov 7 | ||||||
| Interojo | Expected around Nov 7 | ||||||
| Classys | Expected around Nov 10 | ||||||
| Medy-Tox | Expected around Nov 10 | ||||||
| PharmaResearch | Expected around Nov 11 | ||||||
| WON Tech | Expected around Nov 12 | ||||||
| Kangstem Biotech | Expected around Nov 13 | ||||||
| ELC | Expected around Nov 13 | ||||||
| Caregen | Expected around Nov 14 | ||||||
| L&C Bio | Expected around Nov 14 | ||||||
| Humedix | Expected around Nov 14 | ||||||
| Jetema | Expected around Nov 14 | ||||||
| Hironic | Expected around Nov 14 | ||||||
| P&K Skin Research Center | Expected around Nov 14 | ||||||
| Carelabs | Expected around Nov 14 | ||||||
| RollingStone | Expected around Nov 14 | ||||||
| RecensMedical | Not yet | ||||||
| Medyssey | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| 287410 | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Upcoming events
Korea events calendar →Technical breadth
After the close on Oct 29, 2026- Above 20-day average
- 14.3%
- Above 60-day average
- 14.3%
- RSI above 70
- 0%
- RSI below 30
- 21.4%
- 52-week highs
- 0
- 52-week lows
- 2
Index gauge · Short term
Bearish
1 bullish, 1 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 0 neutral, 8 bearish
Technical read
The aesthetics and botox theme covers 14 Korean members, and only 14.3% of them trade above their 20-day and 60-day averages, indicating weak short- and medium-term breadth. None of the members is currently near a 52-week high, while 2 are at a 52-week low, and the lowest member RSI reads 21.4 with no member showing an elevated RSI. The equal-weighted index gauge is bearish on both horizons, with 7 of 9 short-term signals bearish and 8 of 8 medium-term signals bearish, an RSI of 33.3, and the index sitting below its cloud.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 29, 202675Hyundai Department Store: ₩200bn of bonds due in the next 6 months vs ₩158bn cash₩200bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Hyundai Department StoreDaewonkangupHyundai G.F. HoldingsZinusHandsomeSamwonsteel
Aesthetics & botox
−4.05%미용·보톡스
The Aesthetics & Botox theme groups Korean listed companies that develop, manufacture, or distribute botulinum toxin injectables, dermal fillers, and other non-surgical cosmetic treatments, along with related medical aesthetic devices and clinic-linked businesses. Korean investors often cluster these firms together because the country has a large domestic and export market for such products, and many of them share similar regulatory approval processes, overseas licensing deals, and sales patterns tied to global cosmetic demand.
25 companies · 6 up · 1 flat · 18 down
- Traded value
- ₩105B
- Value vs 20-day average
- 0.53×
- Top gainer
- P&K Skin Research Center +9.40%
- Largest company
- APR ₩11T
Companies in this theme
| Company | Price | Weekly | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
APR278470 · KOSPI | ₩282,500 | −2.92% | ₩52B | ₩11T | 7.86% |
Daewoong Pharma069620 · KOSPI | ₩101,500 | −1.36% | ₩1.7B | ₩1.2T | 10.30% |
Dong-A Pharmaceutical000640 · KOSPI | ₩86,300 | −4.85% | ₩763M | ₩581B | 9.45% |
Metacare118000 · KOSPI | ₩1,298 | +0.31% | ₩0 | ₩29B | 0.00% |
Source: KRX statistical information